This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, Hopital Marie Lannelongue. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2024-2025
Title: The Innovations of Samir Messaoudi
Introduction
Samir Messaoudi is a notable inventor based in Chatenay-Malabry, France. He has made significant contributions to the field of medical research, particularly in the development of novel compounds. With a total of 2 patents to his name, Messaoudi's work focuses on advancing therapeutic options for various medical conditions.
Latest Patents
Messaoudi's latest patents include innovative compounds that serve as peripheral NMDA receptor antagonists. The first patent details dizocilpine derivatives, which are designed for use as peripheral NMDA receptor antagonists. This invention aims to provide new avenues for treatment in neurological disorders. The second patent reiterates the same focus on dizocilpine derivatives, emphasizing their potential in medical applications.
Career Highlights
Throughout his career, Messaoudi has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Messaoudi's notable coworkers include Sylvia Cohen-Kaminsky and Marc Humbert. Their collaborative efforts have further enriched the research landscape in which Messaoudi operates.
Conclusion
Samir Messaoudi's contributions to the field of medical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile